{"id":8487,"date":"2025-09-15T11:57:49","date_gmt":"2025-09-15T11:57:49","guid":{"rendered":"https:\/\/lemonn.co.in\/blog\/?p=8487"},"modified":"2025-09-15T11:57:51","modified_gmt":"2025-09-15T11:57:51","slug":"galaxy-medicare-ipo-allotment-gmp-analysis","status":"publish","type":"post","link":"https:\/\/lemonn.co.in\/blog\/ipo\/galaxy-medicare-ipo-allotment-gmp-analysis\/","title":{"rendered":"Galaxy Medicare IPO: A Smart Look at Its Allotment, GMP, and What Investors Should Know"},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"885\" height=\"590\" src=\"https:\/\/lemonn.co.in\/blog\/wp-content\/uploads\/2025\/09\/Galaxy-Medicare-IPO.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Galaxy Medicare IPO: A Smart Look at Its Allotment, GMP, and What Investors Should Know\" style=\"object-fit:cover;\" srcset=\"https:\/\/lemonn.co.in\/blog\/wp-content\/uploads\/2025\/09\/Galaxy-Medicare-IPO.jpg 885w, https:\/\/lemonn.co.in\/blog\/wp-content\/uploads\/2025\/09\/Galaxy-Medicare-IPO-300x200.jpg 300w, https:\/\/lemonn.co.in\/blog\/wp-content\/uploads\/2025\/09\/Galaxy-Medicare-IPO-768x512.jpg 768w\" sizes=\"auto, (max-width: 885px) 100vw, 885px\" \/><\/figure>\n\n\n<h2 id='galaxy-medicare-ipo-what-just-happened'  id=\"boomdevs_1\" class=\"wp-block-heading\">Galaxy Medicare IPO: What Just Happened?<\/h2>\n\n\n\n<p>Galaxy Medicare Limited, a trusted name in the medical devices industry since 1992, recently wrapped up its SME IPO on the NSE Emerge platform. With a goal to raise \u20b922.31 crore, the IPO ran from <strong>September 10 to 12, 2025<\/strong>, and has been a topic of moderate buzz among investors.<\/p>\n\n\n\n<p>Let\u2019s break down the key points: how it performed, what the allotment means, how the grey market reacted, and whether it\u2019s a stock worth holding post-listing.<\/p>\n\n\n\n<h2 id='quick-ipo-highlights'  id=\"boomdevs_2\" class=\"wp-block-heading\">Quick IPO Highlights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Issue Type<\/strong>: SME, Book Building<\/li>\n\n\n\n<li><strong>Price Band<\/strong>: \u20b951 \u2013 \u20b954<\/li>\n\n\n\n<li><strong>Issue Size<\/strong>: \u20b922.31 crore (41.32 lakh shares)<\/li>\n\n\n\n<li><strong>Lot Size<\/strong>: 2,000 shares<\/li>\n\n\n\n<li><strong>Listing Date<\/strong>: September 17, 2025<\/li>\n\n\n\n<li><strong>Registrar<\/strong>: Cameo Corporate Services<\/li>\n<\/ul>\n\n\n\n<h2 id='company-snapshot-what-does-galaxy-medicare-do'  id=\"boomdevs_3\" class=\"wp-block-heading\">Company Snapshot: What Does Galaxy Medicare Do?<\/h2>\n\n\n\n<p>Galaxy Medicare makes essential healthcare products like:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Plaster of Paris bandages<\/li>\n\n\n\n<li>Surgical dressings<\/li>\n\n\n\n<li>Gauze, tapes, and wound care items<\/li>\n<\/ul>\n\n\n\n<p>They supply to both <strong>government health departments<\/strong> and <strong>private hospitals<\/strong>, and export to countries like the UK, Germany, Bangladesh, and Nepal. Their 27+ registered trademarks include names like <strong>POP BAND<\/strong>, <strong>G CAST<\/strong>, and <strong>CARETAPE<\/strong>, signaling a strong brand foundation.<\/p>\n\n\n\n<h2 id='financial-health-check-fy23-fy25'  id=\"boomdevs_4\" class=\"wp-block-heading\">Financial Health Check (FY23\u2013FY25)<\/h2>\n\n\n\n<p>Here\u2019s how the company has been performing financially:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>Year<\/th><th>Revenue (\u20b9 Cr)<\/th><th>EBITDA (\u20b9 Cr)<\/th><th>Net Profit (\u20b9 Cr)<\/th><\/tr><\/thead><tbody><tr><td>2023<\/td><td>32.03<\/td><td>3.14<\/td><td>1.57<\/td><\/tr><tr><td>2024<\/td><td>36.94<\/td><td>5.26<\/td><td>3.71<\/td><\/tr><tr><td>2025<\/td><td>40.27<\/td><td>4.58<\/td><td>3.37<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue<\/strong>: Up 9% YoY in FY25<\/li>\n\n\n\n<li><strong>Profit<\/strong>: Down 9% YoY in FY25<\/li>\n<\/ul>\n\n\n\n<p><em>Why the dip in profit?<\/em> Rising costs and lower margins seem to be squeezing profitability despite growing sales.<\/p>\n\n\n\n<h2 id='ipo-subscription-breakdown'  id=\"boomdevs_5\" class=\"wp-block-heading\">IPO Subscription Breakdown<\/h2>\n\n\n\n<p>The IPO was <strong>subscribed 1.83x overall<\/strong>\u2014not a runaway hit, but not weak either.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>Category<\/th><th>Subscription<\/th><\/tr><\/thead><tbody><tr><td>Retail (RII)<\/td><td>2.10x<\/td><\/tr><tr><td>HNIs (NII)<\/td><td>1.48x<\/td><\/tr><tr><td>Institutions (QIB)<\/td><td>1.00x<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The <strong>retail crowd showed up<\/strong>, but institutional investors played it safe with a minimal 1x subscription. That\u2019s a signal of lukewarm long-term confidence.<\/p>\n\n\n\n<h2 id='grey-market-premium-gmp-a-wild-ride'  id=\"boomdevs_6\" class=\"wp-block-heading\">Grey Market Premium (GMP): A Wild Ride<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Opening GMP<\/strong>: \u20b90<\/li>\n\n\n\n<li><strong>Closing GMP (Sept 12)<\/strong>: \u20b95<\/li>\n\n\n\n<li><strong>Final GMP (Sept 15)<\/strong>: \u20b90<\/li>\n<\/ul>\n\n\n\n<p>The GMP hinted at brief excitement, but fizzled out by allotment day. This pattern suggests <strong>short-lived speculation<\/strong> rather than lasting investor enthusiasm.<\/p>\n\n\n\n<h2 id='how-to-check-your-allotment-status'  id=\"boomdevs_7\" class=\"wp-block-heading\">How to Check Your Allotment Status<\/h2>\n\n\n\n<p>You can check your status in two easy ways:<\/p>\n\n\n\n<h3 id='method-1-registrar-s-website-cameo-corporate'  id=\"boomdevs_8\" class=\"wp-block-heading\">Method 1: Registrar&#8217;s Website (Cameo Corporate)<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Visit <a>Cameo IPO Allotment Page<\/a><\/li>\n\n\n\n<li>Choose \u201cGalaxy Medicare\u201d<\/li>\n\n\n\n<li>Enter your PAN, Application Number, or DP\/Client ID<\/li>\n\n\n\n<li>Complete the captcha and submit<\/li>\n<\/ol>\n\n\n\n<h3 id='method-2-nse-website'  id=\"boomdevs_9\" class=\"wp-block-heading\">Method 2: NSE Website<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Go to <a>NSE IPO Allotment Page<\/a><\/li>\n\n\n\n<li>Select Equity > Galaxy Medicare<\/li>\n\n\n\n<li>Enter PAN and Application Number<\/li>\n\n\n\n<li>Click Submit<\/li>\n<\/ol>\n\n\n\n<h2 id='listing-day-strategy-sell-or-hold'  id=\"boomdevs_10\" class=\"wp-block-heading\">Listing Day Strategy: Sell or Hold?<\/h2>\n\n\n\n<p>Let\u2019s weigh your options:<\/p>\n\n\n\n<h3 id='reasons-to-hold'  id=\"boomdevs_11\" class=\"wp-block-heading\">Reasons to Hold:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Established brand with international presence<\/li>\n\n\n\n<li>Steady revenue growth<\/li>\n\n\n\n<li>Long-term healthcare demand is rising<\/li>\n<\/ul>\n\n\n\n<h3 id='reasons-to-sell'  id=\"boomdevs_12\" class=\"wp-block-heading\">Reasons to Sell:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Profitability is declining<\/li>\n\n\n\n<li>GMP is flat\u2014no obvious listing pop<\/li>\n\n\n\n<li>Institutional interest is neutral<\/li>\n<\/ul>\n\n\n\n<p><strong>Our Take<\/strong>: If you\u2019re a short-term investor, consider exiting early. If you\u2019re long-term and believe in healthcare, hold\u2014but watch the next few quarters closely.<\/p>\n\n\n\n<h2 id='key-takeaways'  id=\"boomdevs_13\" class=\"wp-block-heading\">Key Takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Galaxy Medicare IPO had decent retail support but lacked institutional hype<\/li>\n\n\n\n<li>Financials show growth with shrinking profit margins<\/li>\n\n\n\n<li>GMP was volatile and ended flat\u2014pointing to a measured listing<\/li>\n\n\n\n<li>Allotment results are available from September 15<\/li>\n\n\n\n<li>Listing is scheduled for <strong>September 17 on NSE Emerge<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id='faqs'  id=\"boomdevs_14\" class=\"wp-block-heading\">FAQs<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list \">\n<div id=\"faq-question-1757937394750\" class=\"rank-math-list-item\">\n<h3 id='q-is-galaxy-medicare-a-good-long-term-bet'  id=\"boomdevs_15\" class=\"rank-math-question \"><strong>Q: Is Galaxy Medicare a good long-term bet?<\/strong><\/h3>\n<div class=\"rank-math-answer \">\n\n<p><em>A: It has strong fundamentals and market reach, but recent profit dips suggest watching how it manages costs going forward.<\/em><\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1757937404747\" class=\"rank-math-list-item\">\n<h3 id='q-will-i-make-listing-gains'  id=\"boomdevs_16\" class=\"rank-math-question \"><strong>Q: Will I make listing gains?<\/strong><\/h3>\n<div class=\"rank-math-answer \">\n\n<p><em>A: Unlikely. With GMP at \u20b90, a flat opening is more probable.<\/em><\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1757937412427\" class=\"rank-math-list-item\">\n<h3 id='q-can-i-still-buy-after-listing'  id=\"boomdevs_17\" class=\"rank-math-question \"><strong>Q: Can I still buy after listing?<\/strong><\/h3>\n<div class=\"rank-math-answer \">\n\n<p><em>A: Yes, but only after doing your own due diligence. Watch the first-week price movement and volume.<\/em><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<h2 id='final-thought'  id=\"boomdevs_18\" class=\"wp-block-heading\">Final Thought<\/h2>\n\n\n\n<p>The Galaxy Medicare IPO wasn\u2019t a blockbuster, but it wasn\u2019t a flop either. For investors, it\u2019s a lesson in staying grounded &#8211; don\u2019t chase grey market hype. Let the fundamentals guide your next move.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Galaxy Medicare IPO: What Just Happened? Galaxy Medicare Limited, a trusted name in the medical devices industry since 1992, recently wrapped up its SME IPO on the NSE Emerge platform. With a goal to raise \u20b922.31 crore, the IPO ran from September 10 to 12, 2025, and has been a topic of moderate buzz among [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":8488,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_ayudawp_aiss_exclude":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-8487","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/8487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/comments?post=8487"}],"version-history":[{"count":1,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/8487\/revisions"}],"predecessor-version":[{"id":8489,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/8487\/revisions\/8489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media\/8488"}],"wp:attachment":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media?parent=8487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/categories?post=8487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/tags?post=8487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}